Clinical trial
Study of Taxotere, Cisplatin, 5-Fluorouracil, and Leucovorin for Squamous Cell…
NCT00139243 · Dana-Farber Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00139243 |
|---|---|
| Title | Study of Taxotere, Cisplatin, 5-Fluorouracil, and Leucovorin for Squamous Cell Carcinoma of the Head and Neck |
| Official title | A Phase I/II Study of Taxotere, Cisplatin, 5-Fluorouracil and Leucovorin for Squamous Cell Carcinoma of the Head and Neck |
| Lead sponsor | Dana-Farber Cancer Institute, Other |
| Collaborators | Sanofi Industry Brigham and Women's Hospital Massachusetts General Hospital Beth Israel Deaconess Medical Center |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Squamous Cell Carcinoma, Carcinoma of Head and/or Neck |
| Intervention type | Drug |
| Interventions | Taxotere, Cisplatin, 5-Fluorouracil, Leucovorin |
| Enrollment | 30 |
| Start date | Oct 1, 1997 |
| Primary completion | Jan 1, 2006 |
| Completion | Jan 1, 2006 |
| First posted | Aug 31, 2005 |
| Last update posted | Jun 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: